Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.91
-0.14 (-2.31%)
At close: Jan 6, 2026, 4:00 PM EST
5.98
+0.07 (1.18%)
After-hours: Jan 6, 2026, 6:44 PM EST
Evolus Employees
Evolus had 332 employees as of December 31, 2024. The number of employees increased by 59 or 21.61% compared to the previous year.
Employees
332
Change (1Y)
59
Growth (1Y)
21.61%
Revenue / Employee
$860,913
Profits / Employee
-$176,392
Market Cap
383.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 332 | 59 | 21.61% |
| Dec 31, 2023 | 273 | 58 | 26.98% |
| Dec 31, 2022 | 215 | 48 | 28.74% |
| Dec 31, 2021 | 167 | 48 | 40.34% |
| Dec 31, 2020 | 119 | -116 | -49.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EOLS News
- 22 days ago - AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings - Seeking Alpha
- 7 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evolus Reports Third Quarter 2025 Financial Results - Business Wire
- 2 months ago - Evolus to Participate in 2025 Stifel Healthcare Conference - Business Wire
- 2 months ago - Evolus to Report Third Quarter Financial Results on November 5, 2025 - Business Wire
- 3 months ago - Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch - PRNewsWire
- 4 months ago - Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire